Perspective TherapeuticsCATX
13F holders, Q2 2025 (June 30)2holders
0new positions
0sold out
$4.22avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Perspective Therapeutics Inc. (CATX) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were Portland Investment Counsel Inc. ($940K) and Vestor Capital, LLC ($119K).
- Company
- Perspective Therapeutics Inc.
- CUSIP
- 46489V104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 60,000 shares bought and 973,619 shares sold, net −913,619 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Portland Investment Counsel Inc. | 0.28% | Add +31.6% | 250,000 | $940K |
| Vestor Capital, LLC | 0.01% | Reduce -99.9% | 1,101 | $119K |
"% of holder's portfolio" is CATX's weight in each manager's 13F, not the share of Perspective Therapeutics Inc. the manager owns.